Improve data quality and decision making from proof-of-concept to post-marketing.
Recruiting, retaining, assessing and monitoring participants is challenging, time consuming and costly. So too is the complex and high-risk task of demonstrating a treatment’s efficacy, getting it to market and demonstrating post-market patient outcomes.
At Cambridge Cognition we specialise in scientifically proven digital solutions to address all of these challenges, improving the likelihood of a trial’s success and supporting effective treatments in market.
We provide a range of industry-leading and regulatory-accepted digital products to optimise and accelerate safe, effective and efficient pharmaceutical research and development.
Reduce your risk of failure, get to market faster and demonstrate real-world treatment value with Cambridge Cognition.
Real World Outcomes Data
Digital brain health apps for mobile and wearable devices collecting real-world, patient-centric outcomes data to understand and manage day-to-day brain health in clinical R&D and healthcare.
Online screening to enrich study recruitment. CANTAB Recruit is used by the world’s largest clinical trials, remotely identify suitable participants at scale to cost-effectively accelerate recruitment and reduce on-site screen failures.
Phase I-IV Cognitive Efficacy
Demonstrate the cognitive efficacy of a compound with objective and non-invasive measures of brain function and patient outcomes, aiding decision-making, dose-finding and drug repurposing.
Phase I-IV Cognitive Safety
Safety and tolerability assessments designed to improve data quality and operational efficiencies in early SAD/MAD studies and late phase clinical trials with fast, sensitive measures of cognitive safety outcomes.
Drug Abuse Liability
Fast, accurate and paperless measurement of human abuse potential, patient response and drug liking in clinical trials to improve data quality, participant compliance and trial efficiency.